Article Summary

**Qualigen Therapeutics Stock Rockets 62% on Strategic BitGo Cryptocurrency Partnership** Qualigen Therapeutics Inc. (NASDAQ:QLGN) experienced explosive after-hours trading growth, surging 62% following the announcement of a groundbreaking partnership with leading digital asset custodian BitGo. This collaboration positions QLGN to implement a comprehensive multi-asset cryptocurrency treasury strategy, marking a significant pivot into the blockchain and digital asset ecosystem. The strategic alliance with BitGo, a premier institutional cryptocurrency custody platform, demonstrates QLGN's commitment to diversifying its financial portfolio through digital assets including Bitcoin and other cryptocurrencies. This move reflects the growing trend of traditional companies adopting crypto treasury strategies to hedge against inflation and capitalize on blockchain technology opportunities. BitGo's institutional-grade security infrastructure and multi-signature wallet technology will provide QLGN with secure cryptocurrency storage and management capabilities. The partnership signals potential expansion into DeFi protocols and broader digital asset investment strategies. This dramatic stock price surge underscores investor enthusiasm for corporate cryptocurrency adoption, positioning Qualigen Therapeutics at the intersection of biotechnology and digital finance innovation. The collaboration could establish new precedents for pharmaceutical companies entering the cryptocurrency market.